Cargando…
Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective
BACKGROUND: Despite the symptom overlap between allergic rhinitis (AR) and coronavirus disease 2019 (COVID-19), pandemic-time anxiety in people with AR remains an area of limited study. OBJECTIVE: To assess the AR-anxiety relationship in the unique context of the COVID-19 pandemic from a Canadian pe...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338449/ https://www.ncbi.nlm.nih.gov/pubmed/35918024 http://dx.doi.org/10.1016/j.anai.2022.07.030 |
_version_ | 1784759969683341312 |
---|---|
author | Xu, Kayley Linton, Sophia Sunavsky, Adam Garvey, Sarah Botting, Hannah Steacy, Lisa M. Hopman, Wilma M. Tripp, Dean A. Ellis, Anne K. |
author_facet | Xu, Kayley Linton, Sophia Sunavsky, Adam Garvey, Sarah Botting, Hannah Steacy, Lisa M. Hopman, Wilma M. Tripp, Dean A. Ellis, Anne K. |
author_sort | Xu, Kayley |
collection | PubMed |
description | BACKGROUND: Despite the symptom overlap between allergic rhinitis (AR) and coronavirus disease 2019 (COVID-19), pandemic-time anxiety in people with AR remains an area of limited study. OBJECTIVE: To assess the AR-anxiety relationship in the unique context of the COVID-19 pandemic from a Canadian perspective. METHODS: The COVID-19 Associated Anxiety in patients with Asthma and AR Experiencing Symptoms survey was distributed on the “Qualtrics XM” platform, with 835 adult participants responding to the first iteration from April to August 2020. Anxiety was assessed on the Generalized Anxiety Disorder Assessment-7 (GAD-7), and AR burden of disease was assessed on the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). All analyses were conducted using IBM SPSS Statistics 27. RESULTS: High levels of anxiety were found, with 28.0% of the AR group and 27.5% of the control group meeting the diagnostic criteria for generalized anxiety disorder. After controlling for covariates, AR status had no significant predictive effect on GAD-7 in a hierarchal multiple regression model (ΔR(2) = .00, P = .69). In the AR subgroup, there were significant positive correlations between anxiety and burden of disease for the total RQLQ score and all 7 domain scores (P < .001 for all), with the non-nose or eye symptom domain having the strongest correlation (r = .63). After controlling for covariates, total RQLQ score had a predictive effect on GAD-7 in a hierarchal multiple regression model (ΔR(2) = .049, P < .001). CONCLUSION: High levels of anxiety exist during the COVID-19 pandemic regardless of AR status, indicating the importance of early anxiety screening in all patients. This study also highlights the importance of non-nose or eye symptoms in AR management. |
format | Online Article Text |
id | pubmed-9338449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93384492022-08-01 Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective Xu, Kayley Linton, Sophia Sunavsky, Adam Garvey, Sarah Botting, Hannah Steacy, Lisa M. Hopman, Wilma M. Tripp, Dean A. Ellis, Anne K. Ann Allergy Asthma Immunol Article BACKGROUND: Despite the symptom overlap between allergic rhinitis (AR) and coronavirus disease 2019 (COVID-19), pandemic-time anxiety in people with AR remains an area of limited study. OBJECTIVE: To assess the AR-anxiety relationship in the unique context of the COVID-19 pandemic from a Canadian perspective. METHODS: The COVID-19 Associated Anxiety in patients with Asthma and AR Experiencing Symptoms survey was distributed on the “Qualtrics XM” platform, with 835 adult participants responding to the first iteration from April to August 2020. Anxiety was assessed on the Generalized Anxiety Disorder Assessment-7 (GAD-7), and AR burden of disease was assessed on the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). All analyses were conducted using IBM SPSS Statistics 27. RESULTS: High levels of anxiety were found, with 28.0% of the AR group and 27.5% of the control group meeting the diagnostic criteria for generalized anxiety disorder. After controlling for covariates, AR status had no significant predictive effect on GAD-7 in a hierarchal multiple regression model (ΔR(2) = .00, P = .69). In the AR subgroup, there were significant positive correlations between anxiety and burden of disease for the total RQLQ score and all 7 domain scores (P < .001 for all), with the non-nose or eye symptom domain having the strongest correlation (r = .63). After controlling for covariates, total RQLQ score had a predictive effect on GAD-7 in a hierarchal multiple regression model (ΔR(2) = .049, P < .001). CONCLUSION: High levels of anxiety exist during the COVID-19 pandemic regardless of AR status, indicating the importance of early anxiety screening in all patients. This study also highlights the importance of non-nose or eye symptoms in AR management. American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-11 2022-07-30 /pmc/articles/PMC9338449/ /pubmed/35918024 http://dx.doi.org/10.1016/j.anai.2022.07.030 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Xu, Kayley Linton, Sophia Sunavsky, Adam Garvey, Sarah Botting, Hannah Steacy, Lisa M. Hopman, Wilma M. Tripp, Dean A. Ellis, Anne K. Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective |
title | Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective |
title_full | Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective |
title_fullStr | Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective |
title_full_unstemmed | Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective |
title_short | Anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: A Canadian perspective |
title_sort | anxiety in adults with allergic rhinitis during the coronavirus disease 2019 pandemic: a canadian perspective |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338449/ https://www.ncbi.nlm.nih.gov/pubmed/35918024 http://dx.doi.org/10.1016/j.anai.2022.07.030 |
work_keys_str_mv | AT xukayley anxietyinadultswithallergicrhinitisduringthecoronavirusdisease2019pandemicacanadianperspective AT lintonsophia anxietyinadultswithallergicrhinitisduringthecoronavirusdisease2019pandemicacanadianperspective AT sunavskyadam anxietyinadultswithallergicrhinitisduringthecoronavirusdisease2019pandemicacanadianperspective AT garveysarah anxietyinadultswithallergicrhinitisduringthecoronavirusdisease2019pandemicacanadianperspective AT bottinghannah anxietyinadultswithallergicrhinitisduringthecoronavirusdisease2019pandemicacanadianperspective AT steacylisam anxietyinadultswithallergicrhinitisduringthecoronavirusdisease2019pandemicacanadianperspective AT hopmanwilmam anxietyinadultswithallergicrhinitisduringthecoronavirusdisease2019pandemicacanadianperspective AT trippdeana anxietyinadultswithallergicrhinitisduringthecoronavirusdisease2019pandemicacanadianperspective AT ellisannek anxietyinadultswithallergicrhinitisduringthecoronavirusdisease2019pandemicacanadianperspective |